Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 16
1964 22
1965 13
1966 18
1967 24
1968 13
1969 39
1970 36
1971 58
1972 50
1973 46
1974 77
1975 73
1976 81
1977 80
1978 127
1979 116
1980 105
1981 99
1982 105
1983 135
1984 150
1985 150
1986 188
1987 226
1988 335
1989 444
1990 580
1991 541
1992 640
1993 627
1994 795
1995 755
1996 872
1997 887
1998 1002
1999 1012
2000 1259
2001 1259
2002 1275
2003 1459
2004 1483
2005 1493
2006 1508
2007 1805
2008 1678
2009 1558
2010 1861
2011 1815
2012 1825
2013 1987
2014 1932
2015 2047
2016 2122
2017 2173
2018 1921
2019 1790
2020 2179
2021 2347
2022 2461
2023 1989
2024 21

Text availability

Article attribute

Article type

Publication date

Search Results

49,653 results

Results by year

Filters applied: . Clear all
Page 1
Breast Cancer: Current Perspectives on the Disease Status.
Fahad Ullah M. Fahad Ullah M. Adv Exp Med Biol. 2019;1152:51-64. doi: 10.1007/978-3-030-20301-6_4. Adv Exp Med Biol. 2019. PMID: 31456179 Review.
Breast cancer is the most frequently diagnosed cancer in women and ranks second among causes for cancer related death in women. Evidence in literature has shown that the past and ongoing research has an enormous implication in improving the clinical outcome in breast …
Breast cancer is the most frequently diagnosed cancer in women and ranks second among causes for cancer related death in women. Evide …
Histological type and typing of breast carcinomas and the WHO classification changes over time.
Cserni G. Cserni G. Pathologica. 2020 Mar;112(1):25-41. doi: 10.32074/1591-951X-1-20. Pathologica. 2020. PMID: 32202537 Free PMC article. Review.
The World Health Organization's new classification of breast tumors has just been published. This review aims to examine the morphological categorization of breast carcinomas which is still principally based on histological features and follows the traditions of his …
The World Health Organization's new classification of breast tumors has just been published. This review aims to examine the morpholo …
Overview of breast cancer.
Watkins EJ. Watkins EJ. JAAPA. 2019 Oct;32(10):13-17. doi: 10.1097/01.JAA.0000580524.95733.3d. JAAPA. 2019. PMID: 31513033 Review.
Each year, more than 250,000 women in the United States are diagnosed with invasive breast cancer. Although overall mortality for breast cancer patients has declined, it is still the second most common cause of cancer death in women. This article provides an overvie …
Each year, more than 250,000 women in the United States are diagnosed with invasive breast cancer. Although overall mortality for …
Novel uses of immunohistochemistry in breast pathology: interpretation and pitfalls.
Cimino-Mathews A. Cimino-Mathews A. Mod Pathol. 2021 Jan;34(Suppl 1):62-77. doi: 10.1038/s41379-020-00697-3. Epub 2020 Oct 27. Mod Pathol. 2021. PMID: 33110239 Free article. Review.
Novel immunohistochemistry serves as surrogates for the molecular alterations unique to several of special-type breast carcinomas, including the use of MYB in adenoid cystic carcinoma, pan-TRK in secretory carcinoma, and mutant IDH2 in tall cell carcinoma …
Novel immunohistochemistry serves as surrogates for the molecular alterations unique to several of special-type breast carcinomas, in …
Male Breast Carcinoma: A Clinical and Pathological Review.
Javidiparsijani S, Rosen LE, Gattuso P. Javidiparsijani S, et al. Int J Surg Pathol. 2017 May;25(3):200-205. doi: 10.1177/1066896916675953. Epub 2016 Nov 10. Int J Surg Pathol. 2017. PMID: 27831530 Review.
Male breast carcinomas (MBCs) are rare neoplasms that account for 0.1% of all male cancers. ...Because of its rarity, data regarding the etiology, risk factors, diagnosis, management, and prognosis of MBC are limited. MBC shares some similarities with female brea …
Male breast carcinomas (MBCs) are rare neoplasms that account for 0.1% of all male cancers. ...Because of its rarity, data reg …
Sarcomas of the Breast.
Duncan MA, Lautner MA. Duncan MA, et al. Surg Clin North Am. 2018 Aug;98(4):869-876. doi: 10.1016/j.suc.2018.03.013. Epub 2018 May 21. Surg Clin North Am. 2018. PMID: 30005780 Review.
Diagnostic workup includes breast imaging and core biopsy as in breast epithelial carcinoma. ...Local recurrence rates are high; prognosis remains poor despite on-going advances in the treatment of epithelial breast carcinoma....
Diagnostic workup includes breast imaging and core biopsy as in breast epithelial carcinoma. ...Local recurrence rates …
Lymphoepithelioma-like breast carcinoma.
Koufopoulos N, Syrios J, Papanikolaou A, Misitzis I, Kapatou KA, Dimas D, Khaldi L. Koufopoulos N, et al. Pol J Pathol. 2018;69(1):98-104. doi: 10.5114/pjp.2018.75344. Pol J Pathol. 2018. PMID: 29895134 Free article. Review.
Nasopharyngeal lymphoepithelioma is an undifferentiated carcinoma in a dominated lymphoplasma-histiocyte stroma. Lymphoepithelioma-like carcinoma of the breast is the mammary counterpart of the lymphoepithelioma of the nasopharynx and is characterised by prol …
Nasopharyngeal lymphoepithelioma is an undifferentiated carcinoma in a dominated lymphoplasma-histiocyte stroma. Lymphoepithelioma-li …
Metaplastic Breast Carcinoma Revisited; Subtypes Determine Outcomes: Comprehensive Pathologic, Clinical, and Molecular Review.
Khoury T. Khoury T. Surg Pathol Clin. 2022 Mar;15(1):159-174. doi: 10.1016/j.path.2021.11.011. Epub 2022 Jan 31. Surg Pathol Clin. 2022. PMID: 35236632 Review.
Metaplastic breast carcinoma (MpBC) is a heterogeneous group of tumors that clinically could be divided into low risk and high risk. It is important to recognize the different types of MpBC, as the high-risk subtypes have worse clinical outcomes than triple-negative …
Metaplastic breast carcinoma (MpBC) is a heterogeneous group of tumors that clinically could be divided into low risk and high …
Secretory breast carcinoma: a clinicopathological and immunophenotypic study of 15 cases with a review of the literature.
Li D, Xiao X, Yang W, Shui R, Tu X, Lu H, Shi D. Li D, et al. Mod Pathol. 2012 Apr;25(4):567-75. doi: 10.1038/modpathol.2011.190. Epub 2011 Dec 9. Mod Pathol. 2012. PMID: 22157932 Free article. Review.
Secretory breast carcinoma is a rare breast cancer with indolent clinical behavior. Recent research showed that secretory breast carcinoma belongs to the phenotypic spectrum of basal-like breast carcinomas. ...
Secretory breast carcinoma is a rare breast cancer with indolent clinical behavior. Recent research showed that secreto …
Microglandular Adenosis and Associated Invasive Carcinoma.
Kravtsov O, Jorns JM. Kravtsov O, et al. Arch Pathol Lab Med. 2020 Jan;144(1):42-46. doi: 10.5858/arpa.2019-0049-RA. Epub 2019 May 22. Arch Pathol Lab Med. 2020. PMID: 31116044 Free article. Review.
When associated with cancer, microglandular adenosis and associated invasive carcinoma share the same molecular alterations, including TP53 mutation; therefore, microglandular adenosis is considered a nonobligate precursor of triple (HER2/neu, estrogen and progesterone rec …
When associated with cancer, microglandular adenosis and associated invasive carcinoma share the same molecular alterations, includin …
49,653 results
You have reached the last available page of results. Please see the User Guide for more information.